Literature DB >> 11861673

Increased formation of lysophosphatidic acids by lysophospholipase D in serum of hypercholesterolemic rabbits.

Akira Tokumura1, Yumi Kanaya, Masaki Kitahara, Maki Miyake, Yasuko Yoshioka, Kenji Fukuzawa.   

Abstract

Lysophosphatidic acid (LPA) is a biologically active phospholipid that has been identified as a vasoactive principle in incubated plasma and serum of mammals. Previously, we found that mammalian plasma and serum contain a lysophospholipase D, which hydrolyzes lysophosphatidylcholines (LPCs) with different fatty acyl groups to the corresponding LPAs during its incubation at 37 degree C. In this study, we examined whether lysophospholipase D activity and levels of LPCs in rabbit serum were modulated by feeding rabbits a high cholesterol diet. Results showed that the serum levels of LPCs increased gradually in animals fed a high cholesterol diet for 12 weeks. We found that the levels of individual LPAs formed on incubation of serum for 24 h increased with an increase in the period of feeding of rabbits a high cholesterol diet. LPA with a linoleate residue was the most abundant LPA, followed in order by 16:0-, 18:1- and 18:0-LPAs. LPA was found to increase attachment of the monocytic cell line THP-1 to vascular endothelial cells pre-stimulated with tumor necrosis factor-alpha. These results indicated that increases in the levels of LPAs generated by lysophospholipase D in the blood of hypercholesterolemic rabbits may be relevant to attachment of monocytes to vascular walls, a key phenomenon observed at an early stage of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861673

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  17 in total

Review 1.  Lysophospholipids in coronary artery and chronic ischemic heart disease.

Authors:  Ahmed Abdel-Latif; Paula M Heron; Andrew J Morris; Susan S Smyth
Journal:  Curr Opin Lipidol       Date:  2015-10       Impact factor: 4.776

Review 2.  High-fat diet, obesity and prostate disease: the ATX-LPA axis?

Authors:  Prakash Kulkarni; Robert H Getzenberg
Journal:  Nat Clin Pract Urol       Date:  2009-02-10

3.  CD14 is a key mediator of both lysophosphatidic acid and lipopolysaccharide induction of foam cell formation.

Authors:  Dong An; Feng Hao; Fuqiang Zhang; Wei Kong; Jerold Chun; Xuemin Xu; Mei-Zhen Cui
Journal:  J Biol Chem       Date:  2017-07-13       Impact factor: 5.157

4.  Atherosclerotic lesion progression changes lysophosphatidic acid homeostasis to favor its accumulation.

Authors:  Martine Bot; Ilze Bot; Rubén Lopez-Vales; Chris H A van de Lest; Jean Sébastien Saulnier-Blache; J Bernd Helms; Samuel David; Theo J C van Berkel; Erik A L Biessen
Journal:  Am J Pathol       Date:  2010-04-29       Impact factor: 4.307

Review 5.  Lysophospholipid mediators in the vasculature.

Authors:  Paul Mueller; Shaojing Ye; Andrew Morris; Susan S Smyth
Journal:  Exp Cell Res       Date:  2015-03-28       Impact factor: 3.905

6.  Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.

Authors:  Daniel L Baker; Yuko Fujiwara; Kathryn R Pigg; Ryoko Tsukahara; Susumu Kobayashi; Hiromu Murofushi; Ayako Uchiyama; Kimiko Murakami-Murofushi; Eunjin Koh; Russell W Bandle; Hoe-Sup Byun; Robert Bittman; Dominic Fan; Mandi Murph; Gordon B Mills; Gabor Tigyi
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

7.  LPA receptor 4 deficiency attenuates experimental atherosclerosis.

Authors:  Liping Yang; Maria Kraemer; Xianjun Frank Fang; Peggi M Angel; Richard R Drake; Andrew J Morris; Susan S Smyth
Journal:  J Lipid Res       Date:  2019-02-22       Impact factor: 5.922

Review 8.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

9.  Lysophosphatidic acid stimulates the intestinal brush border Na(+)/H(+) exchanger 3 and fluid absorption via LPA(5) and NHERF2.

Authors:  Songbai Lin; Sunil Yeruva; Peijian He; Anurag Kumar Singh; Huanchun Zhang; Mingmin Chen; Georg Lamprecht; Hugo R de Jonge; Ming Tse; Mark Donowitz; Boris M Hogema; Jerold Chun; Ursula Seidler; C Chris Yun
Journal:  Gastroenterology       Date:  2009-10-01       Impact factor: 22.682

Review 10.  Lysophosphatidic acid in atherosclerotic diseases.

Authors:  Andreas Schober; Wolfgang Siess
Journal:  Br J Pharmacol       Date:  2012-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.